Paradromics announced on 17 June 2026 that University of Michigan surgeons have implanted its Connexus brain-computer interface in a woman with motor neuron disease, the first patient in the FDA-approved Connect-One early feasibility study. She will be followed for six years.
Vivani Medical announced on 2 July 2026 an all-stock reverse-merger agreement to combine its Cortigent subsidiary with Nasdaq-listed ClearOne, forming Cortigent Holdings, Inc. under the expected ticker CRGT. Vivani will hold between 59.4 and 67.5 per cent of the combined company; the deal requires a concurrent 10 to 15 million dollar registered offering and is targeted to close in the third quarter of 2026.
Tianyu Jia and Dario Farina at Imperial College London, with collaborators at Tsinghua University and Southeast University Nanjing, published a Nature Communications paper on 2 July 2026 describing a tactile-encoded non-invasive BCI in which ten healthy participants controlled four supernumerary robotic degrees of freedom concurrently with a bimanual ball-balancing task, reaching 74.79 per cent single-task and 59.69 per cent dual-task online accuracy after three days of training.
Sisen Technology, founded in December 2025 by Tsinghua and ETH Zurich alumni, raised tens of millions of yuan in seed funding co-led by Inno Angel Fund and Tsinghua Alumni Seed Fund, targeting glioblastoma blood-brain-barrier opening as its first indication.
Naomi du Bois and Damien Coyle at the University of Bath and Ulster University published a Nature Communications Medicine paper on 17 April 2026, press-released by Bath on 30 June, showing a multi-session wearable EEG motor-imagery BCI lifted minimally-conscious-state detection from 39 to 69 per cent across 42 brain-injury patients.
Meta AI released Brain2Qwerty v2 on 29 June 2026: a non-invasive system that decoded typed sentences from MEG brain signals at 61 per cent average word accuracy across nine healthy volunteers.
Aurenar, a Washington University neurosurgery spinout led by Eric Leuthardt, received FDA Breakthrough Device Designation on 30 June 2026 for the V-Link System, a non-invasive transauricular vagus nerve stimulator targeting cerebral vasospasm in aneurysmal subarachnoid hemorrhage patients.
Giacomo Valle at Chalmers and co-authors from Pittsburgh, Amsterdam and Miguel Hernández University published a Nature Reviews Bioengineering paper on 1 June 2026 arguing that fifty years of parallel work on visual and somatosensory cortical microstimulation prostheses have converged into a single engineering discipline.
Fluent, a Melbourne biomedical engineering spinout founded in May 2025, has raised over two million dollars in seed capital to develop InScribe, a sub-scalp EEG device for speech decoding in patients with motor neurone disease and multiple sclerosis, with first-in-human surgery targeted for 2026.
Get the latest BCI news, breakthroughs, and market moves delivered to your inbox.
No spam. One-click unsubscribe. We respect your privacy.